Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
BackgroundHypereosinophilic syndrome (HES) is characterized by persistent elevated blood and/or tissue eosinophil levels and eosinophil-mediated organ damage. Presentation is highly heterogenous; patients may experience symptoms affecting multiple organ systems.ObjectivesTo assess the effects of mep...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2023-03-01
|
| Colección: | Frontiers in Medicine |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1035250/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|